• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们应如何量化哮喘控制?一项提议。

How should we quantify asthma control? A proposal.

作者信息

Boulet Louis-Philippe, Boulet Véronique, Milot Joanne

机构信息

Centre de recherche de l'Hôpital Laval, Institut de cardiologie et de pneumologie de l'Université Laval, 2725 chemin Sainte-Foy, Sainte-Foy, Québec, Canada.

出版信息

Chest. 2002 Dec;122(6):2217-23. doi: 10.1378/chest.122.6.2217.

DOI:10.1378/chest.122.6.2217
PMID:12475866
Abstract

BACKGROUND

Current asthma guidelines suggest a series of criteria to assess if asthma is controlled. However, there is a need to develop a simple and practical method to quantify the degree of such control, both in clinical practice and research.

STUDY OBJECTIVES

This report describes a new method to quantify asthma control based on a percentage score. It also aims at comparing the percentage scores obtained with patient's self-evaluation of asthma control and a current validated Mini Asthma Quality of Life (MAQOL) questionnaire.

SETTING AND SUBJECTS

Forty-two subjects (25 female and 17 male patients) with asthma of different severity recruited from a tertiary center asthma clinic.

METHODS

The asthma scoring method provided a percentage control for symptoms, baseline expiratory flows and, an optional parameter, for airway inflammation assessed from induced-sputum eosinophil count. These control parameters were compared to an overall assessment of asthma control by the patient (also on a 100% scale) and the score obtained from a validated MAQOL questionnaire.

RESULTS

Mean +/- SEM scores for symptoms, expiratory flows, and airway eosinophilia (last 2 weeks) were 87.8 +/- 1.4%, 88.6 +/- 1.8%, and 66.2 +/- 3.9%, respectively. No significant correlation was found between these three parameters (p > 0.05). The mean global asthma control score and the score estimated by the patient were 80.9 +/- 1.5% and 91.7 +/- 1.5%, respectively (not significantly different). There was a significant correlation between asthma control score (percentage) and percentage symptom score (p < 0.001), while it almost achieved significance for FEV(1) (p = 0.05). Only symptom scores correlated with the MAQOL questionnaire.

CONCLUSIONS

We developed a simple easy-to-use asthma control scoring system based on a percentage of optimal control. The percentage symptom score but not the global control score of this new method correlated with patient's global assessment of asthma control. This could be a simple tool that is potentially useful both for the clinician and for research purposes, to quantify global or specific aspects of asthma control.

摘要

背景

当前哮喘指南提出了一系列评估哮喘是否得到控制的标准。然而,在临床实践和研究中,都需要开发一种简单实用的方法来量化这种控制程度。

研究目的

本报告描述了一种基于百分比评分来量化哮喘控制的新方法。它还旨在比较通过患者对哮喘控制的自我评估以及当前经过验证的小型哮喘生活质量(MAQOL)问卷所获得的百分比评分。

研究地点和对象

从一家三级中心哮喘诊所招募了42名不同严重程度的哮喘患者(25名女性和17名男性)。

方法

哮喘评分方法针对症状、基线呼气流量以及一个可选参数(根据诱导痰嗜酸性粒细胞计数评估气道炎症)给出控制百分比。将这些控制参数与患者对哮喘控制的总体评估(同样采用100%量表)以及从经过验证的MAQOL问卷获得的评分进行比较。

结果

症状、呼气流量以及气道嗜酸性粒细胞(过去2周)的平均±标准误评分为87.8±1.4%、88.6±1.8%和66.2±3.9%, respectively。这三个参数之间未发现显著相关性(p>0.05)。哮喘总体控制评分和患者估计的评分分别为80.9±1.5%和91.7±1.5%(无显著差异)。哮喘控制评分(百分比)与症状评分百分比之间存在显著相关性(p<0.001),而对于第一秒用力呼气容积(FEV(1))几乎达到显著水平(p = 0.05)。只有症状评分与MAQOL问卷相关。

结论

我们基于最佳控制的百分比开发了一种简单易用的哮喘控制评分系统。这种新方法的症状评分百分比而非总体控制评分与患者对哮喘控制的总体评估相关。这可能是一种对临床医生和研究目的都潜在有用的简单工具,用于量化哮喘控制的总体或特定方面。

相似文献

1
How should we quantify asthma control? A proposal.我们应如何量化哮喘控制?一项提议。
Chest. 2002 Dec;122(6):2217-23. doi: 10.1378/chest.122.6.2217.
2
[Relation between clinical severity of bronchial asthma and degree of airway inflammation assessed by the eosinophilic leukocyte count in induced sputum].[支气管哮喘临床严重程度与诱导痰中嗜酸性粒细胞计数评估的气道炎症程度之间的关系]
Vnitr Lek. 2001 Sep;47(9):604-8.
3
Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control.哮喘控制测试(ACT):与哮喘控制的临床、功能和生物学标志物的比较
J Asthma. 2012 Apr;49(3):317-23. doi: 10.3109/02770903.2012.661008. Epub 2012 Mar 9.
4
Correlation of eosinophil counts in induced sputum and fractional concentration of exhaled nitric oxide and lung functions in patients with mild to moderate asthma.诱导痰中嗜酸性粒细胞计数与呼出一氧化氮分数浓度及轻中度哮喘患者肺功能的相关性。
Chin Med J (Engl). 2012 Sep;125(17):3157-60.
5
[The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].[持续性哮喘患者痰液嗜酸性粒细胞与吸入糖皮质激素治疗反应之间的关系]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jun;30(6):447-51.
6
[Airway inflammation and peripheral airway function in asthmatic patients with different control levels].不同控制水平哮喘患者的气道炎症与外周气道功能
Zhonghua Jie He He Hu Xi Za Zhi. 2009 Sep;32(9):679-84.
7
Discrepancies between asthma control criteria in asthmatic patients with and without obesity.有肥胖症和无肥胖症的哮喘患者在哮喘控制标准上的差异。
Obesity (Silver Spring). 2016 Sep;24(9):1854-60. doi: 10.1002/oby.21568. Epub 2016 Jul 28.
8
Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic?我们能否通过临床评估预测转诊至成人哮喘门诊患者的痰嗜酸性粒细胞增多症?
Intern Med J. 2013 Jan;43(1):46-52. doi: 10.1111/j.1445-5994.2011.02565.x.
9
[Control of asthma symptoms and cellular markers of inflammation in induced sputum in children and adolescents with chronic asthma].[慢性哮喘儿童和青少年诱导痰中哮喘症状及炎症细胞标志物的控制]
Pol Merkur Lekarski. 2009 Mar;26(153):178-83.
10
[Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].[哮喘和慢性阻塞性肺疾病患者诱导痰中金属蛋白酶-9/金属蛋白酶组织抑制剂-1及其与气道炎症和气流受限的关系]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Mar;30(3):192-6.

引用本文的文献

1
Effect of adjuvant yoga therapy for asthma control: A randomized controlled trial.辅助瑜伽疗法对哮喘控制的效果:一项随机对照试验。
J Ayurveda Integr Med. 2024 Jan-Feb;15(1):100847. doi: 10.1016/j.jaim.2023.100847. Epub 2024 Jan 17.
2
S100A alarmins and thymic stromal lymphopoietin (TSLP) regulation in severe asthma following bronchial thermoplasty.支气管热成形术治疗后严重哮喘中 S100A 警报素和胸腺基质淋巴细胞生成素 (TSLP) 的调节。
Respir Res. 2023 Nov 23;24(1):294. doi: 10.1186/s12931-023-02604-1.
3
The reduction of airway smooth muscle by bronchial thermoplasty stands the test of time.
支气管热成形术对气道平滑肌的减少效果经得起时间的考验。
ERJ Open Res. 2023 Jul 3;9(4). doi: 10.1183/23120541.00024-2023. eCollection 2023 Jul.
4
Misperception of poor asthma control in the outpatients clinic of a tertiary hospital in Rio de Janeiro.里约热内卢一家三级医院门诊中对哮喘控制不佳的误判
Einstein (Sao Paulo). 2022 Jan 5;19:eAO6259. doi: 10.31744/einstein_journal/2021AO6259. eCollection 2022.
5
Longitudinal comparison of outcomes in patients with smoking-related asthma-COPD overlap and in non-smoking asthmatics with incomplete reversibility of airway obstruction.吸烟相关哮喘-慢性阻塞性肺疾病重叠综合征患者与气道阻塞不完全可逆的非吸烟哮喘患者结局的纵向比较。
Int J Chron Obstruct Pulmon Dis. 2019 Feb 27;14:493-498. doi: 10.2147/COPD.S192003. eCollection 2019.
6
Factors Contributing Towards Poor Asthma Control in Patients on Regular Medication.规律用药患者哮喘控制不佳的相关因素
J Clin Diagn Res. 2016 Jun;10(6):OC31-5. doi: 10.7860/JCDR/2016/18670.8052. Epub 2016 Jun 1.
7
Clinical asthma phenotypes in the real world: opportunities and challenges.现实世界中的临床哮喘表型:机遇与挑战。
Breathe (Sheff). 2015 Sep;11(3):186-93. doi: 10.1183/20734735.008115.
8
Effect of gastroesophageal reflux disease on disease severity and characteristics of lung functional changes in patients with asthma.胃食管反流病对哮喘患者疾病严重程度及肺功能变化特征的影响。
J Cardiovasc Thorac Res. 2014;6(4):223-8. doi: 10.15171/jcvtr.2014.016. Epub 2014 Dec 30.
9
Validation of Persian Version of Asthma Control Test Based on new Global Initiative for Asthma Guidelines.基于新全球哮喘防治创议指南的哮喘控制测试波斯语版本的验证
Tanaffos. 2011;10(4):49-53.
10
Promotion of lung health: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.促进肺部健康:NHLBI 关于慢性肺部疾病一级预防的研讨会。
Ann Am Thorac Soc. 2014 Apr;11 Suppl 3(Suppl 3):S125-38. doi: 10.1513/AnnalsATS.201312-451LD.